J&J Acquire Shockwave Medical for over $13 Billion

Johnson & Johnson has finalised an agreement to purchase Shockwave Medical for $13.1 billion.  

The medical corporation announced that it will offer $335 per share to procure Shockwave, renowned for its expertise in producing catheter-based therapy. Shockwaves device has been utilised in treating around 400,000 individuals worldwide.  

Shockwave’s innovative therapeutics holds a dominant position in addressing calcified arterial lesions, a leading cause of cardiac conditions.  

Joaquin Duato, the leading officer at J&J, stated that the procurement offered “a unique opportunity to accelerate our impact in cardiovascular intervention and drive greater value for patients, shareholders, and health systems.” 

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.